Clinical Trials on Advanced Colorectal Carcinoma in Switzerland

Total 583 results

Merck Sharp & Dohme LLC

Recruiting

A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

Advanced or Metastatic Solid Tumors

Canada, Switzerland, United States
Novartis Pharmaceuticals

Completed

A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

Metastatic or Locally Advanced Solid Tumors

Netherlands, Spain, Germany, Switzerland, Belgium
University of Bern

Completed

Impact of Microparticles on Postoperative Complications in Surgical Patients

Colorectal Neoplasms | Pancreatic Neoplasms | Neoplasm, Hepatic

Switzerland
Swiss Group for Clinical Cancer Research

Completed

External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
Guerbet

Completed

Hepatic Xenetix-CT Perfusion

Hepatocellular Carcinoma

Germany, Switzerland, Korea, Republic of, Austria
Cantonal Hospital of St. Gallen

Terminated

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

Epithelial Ovarian Cancer | Fallopian Tube Carcinoma

Switzerland
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Advanced Solid Tumors

Canada, United States, Spain, France, Switzerland
University of Zurich

Completed

Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases

Switzerland, France, Spain
Hoffmann-La Roche
Sanofi-Synthélabo (Schweiz) AG

Completed

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Rectal Cancer

Switzerland
University Hospital, Basel, Switzerland
Kantonsspital Aarau; Luzerner Kantonsspital; Spital Limmattal Schlieren; Hospital... and other collaborators

Completed

Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections

Colorectal Cancer | Anastomotic Leak | Surgery--Complications | Colorectal Disorders | Complication of Surgical Procedure

Switzerland
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Advanced Solid Tumors

United States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
University of Basel

Recruiting

Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland (CASCADE)

Lynch Syndrome | Hereditary Breast and Ovarian Cancer

Switzerland
Bristol-Myers Squibb

Active, not recruiting

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Advanced Cancer

France, United States, Spain, Australia, Italy, Switzerland, United Kingdom
Kantonsspital Winterthur KSW

Recruiting

Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction (iRARC-KSW)

Complication of Surgical Procedure | Urothelial Carcinoma | Urinary Diversion | Robotic Surgical Procedures | Complication, Postoperative | Cystectomy | Ileal Conduit | Neobladder

Switzerland
University of Zurich

Completed

Closed vs. Open Face Masks for Cranial Radiotherapy

Small Cell Lung Cancer | Brain Tumor | Meningioma | Brain Metastases

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer

Pancreatic Adenocarcinoma

Switzerland
Merck Sharp & Dohme LLC

Recruiting

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Advanced Solid Tumors | Metastatic Solid Tumors

Canada, Switzerland, United States
Oncology Institute of Southern Switzerland
Institute of Oncology Research

Recruiting

The Immune Landscape of Epithelial Ovarian Cancer (IOSI-GYNE-001)

Epithelial Ovarian Cancer

Switzerland
Bristol-Myers Squibb

Terminated

An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer (FRACTION-Lung)

Advanced Cancer

United States, Spain, France, Austria, Italy, Australia, Canada, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer (RECAP)

Rectal Cancer

Switzerland
Cantonal Hospital of St. Gallen

Recruiting

Abdominal or Transanal TME for Rectal Cancer Therapy

Recurrence | Mortality | Survival | Postoperative Morbidity

Switzerland
University Hospital, Geneva
University of Zurich; University of Lausanne Hospitals

Completed

Molecular Biology of Anal Cancer in HIV-Positive Patients

HIV Infections | Carcinoma

Switzerland
Andreas Arnold

Completed

EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients (EBVER/TMC)

Immunosuppression | Neoplasm

Switzerland
NovoCure Ltd.

Completed

NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer

NSCLC | Non-small Cell Lung Cancer

Switzerland
University Hospital, Basel, Switzerland
Department of Urology, University Hospital Freiburg, Freiburg, Germany; Department...

Completed

Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population

Prostate Cancer | Localized Carcinoma

Switzerland
University Hospital, Basel, Switzerland
Sanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer League

Completed

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma (GEMOXEL)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Switzerland
Novartis Pharmaceuticals

Terminated

A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors

Advanced Solid Tumors

Spain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
Kantonsspital Winterthur KSW

Unknown

Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study

Peritoneal Carcinomatosis

Switzerland
Markus Joerger
University of Basel

Completed

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Non Small-cell Lung Cancer | Renal-cell Cancer | Gastrointestinal Stroma Tumor

Switzerland
Hôpital Fribourgeois

Recruiting

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (BAZE)

Pancreas Cancer

Switzerland
University of Zurich

Withdrawn

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

Adenocarcinoma | Stomach Cancer | Cancer of Esophagogastric Junction

Switzerland
Kai-Uwe Schmitt, PhD, MEng, ICID

Recruiting

Digital Lifestyle Intervention for Lung Cancer Survivors After Inpatient Rehabilitation (QUALUCA)

Non-Small Cell Lung Cancer (NSCLC)

Switzerland
University of Lausanne Hospitals

Completed

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

Carcinoma, Hepatocellular | Alcoholic Cirrhosis | Viral Cirrhosis | Postoperative Hepatic Failure

Switzerland
NovoCure Ltd.

Unknown

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Pancreatic Adenocarcinoma

Spain, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Colorectal Cancer

Switzerland
Servier Affaires Médicales

Active, not recruiting

Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective (PROMETCO)

Metastatic Colorectal Cancer

Netherlands, Belgium, Spain, France, Italy, Sweden, Slovenia, Germany, Argentina, Austria, Croatia, Czechia, Greece, Hungary, Ireland, Portugal, Switzerland, United Kingdom
Amgen

Active, not recruiting

A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Non-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid Tumors

United States, Australia, Switzerland
European Organisation for Research and Treatment...

Completed

Synergism of Immunomodulation and Tumor Ablation (ILOC)

Colorectal Cancer | Liver Metastases

France, Netherlands, Switzerland, Germany, Austria, Sweden
NovoCure Ltd.

Unknown

Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)

Ovarian Carcinoma

Switzerland, Belgium, Germany, Spain
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
ETOP IBCSG Partners Foundation

Completed

Afatinib in NSCLC With HER2 Mutation (NICHE)

NSCLC

Switzerland, Germany, Spain, Netherlands
Michel Adamina, MD
University of Zurich; University Hospital, Geneva; University Hospital, Basel... and other collaborators

Suspended

The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study

Colorectal Cancer | Crohn Disease | Anastomotic Leak | Ulcerative Colitis | Diverticulosis | Mesenteric Ischemia

Switzerland
PharmaMar

Completed

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

Advanced Solid Tumors

Spain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
Swiss Group for Clinical Cancer Research

Completed

Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer

Colorectal Cancer

Switzerland, Germany
Pfizer

Completed

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer

Colorectal Cancer

France, Italy, United Kingdom, Belgium, Egypt, Germany, Switzerland, Portugal, Spain, Austria
Stiftung Swiss Tumor Institute
Klinik Hirslanden, Zurich; Manja Gideon Foundation

Terminated

The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer (ECOvar)

Ovarian Neoplasms | Patient Reported Outcome Measures

Switzerland
ETOP IBCSG Partners Foundation
Bristol-Myers Squibb; Frontier Science Foundation, Hellas

Completed

NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma (NICOLAS)

Non-small Cell Lung Cancer Stage III

Switzerland, Netherlands, Spain, Belgium, Germany
European Organisation for Research and Treatment...
Roche Pharma AG; Amgen

Terminated

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases (BOS2)

Colorectal Cancer Metastatic | Liver Metastases | KRAS Wild Type Colorectal Cancer

France, Belgium, Austria, Netherlands, Spain, Switzerland
Hoffmann-La Roche

Terminated

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)

Colorectal Cancer

United States, Korea, Republic of, Australia, France, Switzerland

Clinical Trials on Advanced Colorectal Carcinoma in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations